Evaluation of Oral Clarithromycin in the Treatment of Cutaneous Leishmaniasis in Moroccan Children: A Series of 64 Patients.

Cutaneous leishmaniasis (CL) is commonly seen in pediatric patients in endemic areas, including Morocco. This retrospective, single center study details 64 confirmed pediatric cases of CL treated with oral clarithromycin 15 mg/kg/day for 10 days per month, for a total of three months. Lesions improved in 96.8% of cases and the treatment was well tolerated. Clarithromycin seems a safe and effective alternative to intralesional injections of meglumine antimoniate.